Cannabis rescheduling in the US, a landmark legislative move that has held the attention of the global cannabis industry since...

Canada’s medical cannabis market has continued to decline post-legalization, new figures from Health Canada have shown. In the final quarter...

Cannabis rescheduling is ‘likely’ to take place before the upcoming presidential election, according to new analysis from the Bank of...

President Joe Biden has officially confirmed that cannabis is set to be rescheduled from a Schedule I substance to a...

Germany’s Federal Minister of Food and Agriculture has suggested that the country’s controversial ‘intoxication clause’ could soon be scrapped. During...

New York’s beleaguered cannabis regulators have been hit with another lawsuit that seeks to invalidate hundreds of licenses in the...

Cresco Labs, one of the largest medical cannabis producers in Ohio, has planted its first crop of nearly 1000 cannabis...

Celadon Pharmaceuticals   Celadon Pharmaceuticals this week released its full-year results for 2023, reporting revenues over three times those seen...

As earnings season gets into full swing, Canada’s Organigram has become the latest major cannabis operator to publish its financial...

Last week, UK biotechnology firm Oxford Cannabinoid Technologies (OCT), one of the first cannabis companies in history to list on...